← All organizations

Kiniksa Pharmaceuticals, Ltd.

For profitWebsite ↗

Also known as: Kiniksa | Kiniksa Pharmaceuticals, GmbH | Kiniksa Pharmaceuticals International, plc | Kiniksa Pharmaceuticals, Ltd. | Kiniksa Pharmaceuticals (UK), Ltd. | KINIKSA PHARMACEUTICALS (UK), LTD.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jan 31, 2026

Timeline

2000s

Feb 27, 2008
rilonacept— Marketing Organization
Feb 27, 2008
rilonacept— NDA Secondary Org

2010s

Sep 1, 2015
Kiniksa Pharmaceuticals, Ltd.— Founded

Drugs by trial phase (5 distinct, 14 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

rilonacept

Recent trials (22)

NCT07288216CollaboratorPhase 2Jan 31, 2026
NCT07288216Lead sponsorPhase 2Jan 31, 2026
NCT07010159CollaboratorPhase 2/Phase 3Oct 31, 2025
NCT07010159Lead sponsorPhase 2/Phase 3Oct 31, 2025
NCT06531395Lead sponsorPhase 2Jul 17, 2024
NCT06531395CollaboratorPhase 2Jul 17, 2024
NCT05198310Lead sponsorPhase 2Dec 14, 2021
NCT04463004CollaboratorPhase 2Sep 2, 2020
NCT04447469Lead sponsorPhase 2/Phase 3Jul 27, 2020
NCT04492514CollaboratorPhase 2May 20, 2020
NCT04399980CollaboratorPhase 2May 20, 2020
NCT04497662Lead sponsorPhase 1Oct 22, 2019
NCT03858634Lead sponsorPhase 2May 29, 2019
NCT03858634Study directorPhase 2May 29, 2019
NCT03816891Lead sponsorPhase 2Mar 6, 2019

Details

Founded: Lexington, MA, US Sep 1, 2015
Last known activity: Jan 31, 2026